TCL Archive Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors March 28, 2014
TCL Archive In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay March 28, 1980
TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013